IPCI
COM:INTELLIPHARMACEUTICS
Intellipharmaceutics International
- Stock
Last Close
0.09
05/03 15:01
Market Cap
2.65M
Beta: -
Volume Today
16.90K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Nov '13 | Nov '14 | Nov '15 | Nov '16 | Nov '17 | Nov '18 | Nov '19 | Nov '20 | Nov '21 | Nov '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -11.50M - | -3.86M 66.45% | -7.44M 92.83% | -10.14M 36.40% | -8.86M 12.68% | -13.75M 55.21% | -8.08M 41.19% | -3.39M 58.06% | -5.15M 51.73% | -2.89M 43.78% | |
depreciation and amortization | 396.81K - | 381.38K 3.89% | 377.85K 0.93% | 385.21K 1.95% | 520.84K 35.21% | 612.74K 17.64% | 506.69K 17.31% | 415.38K 18.02% | 261.52K 37.04% | 206.06K 21.21% | |
deferred income tax | 4.29M - | 3.06K 99.93% | 32.96K 978.18% | 22.92K 30.47% | 123.85K 440.44% | 52.61K 57.52% | -11.04K 120.99% | 574.10K 5,299.21% | -93.85K 116.35% | -5.52K 94.12% | |
stock based compensation | 1.15M - | 1.75M 51.54% | 417.82K 76.11% | 2.26M 441.25% | 1.75M 22.62% | 927.69K 46.99% | 264.57K 71.48% | 71.64K 72.92% | 11.98K 83.27% | -50.20K 518.82% | |
change in working capital | -1.47M - | -139.68K 90.52% | 2.77M 2,082.74% | 1.11M 59.99% | -30.24K 102.73% | -603.44K 1,895.25% | 620.37K 202.80% | 1.68M 170.35% | 1.42M 15.15% | 1.27M 10.75% | |
accounts receivables | -1.47M - | 464.61K 131.54% | 532.46K 14.60% | 6.20K 98.84% | -283.99K 4,680.55% | 450.56K 258.65% | 61.86K 86.27% | -389.18K 729.12% | 566.38K 245.53% | -602 100.11% | |
inventory | -115.67K - | -135.98K 17.57% | -97.48K 28.32% | ||||||||
accounts payables | 819.42K - | -618.01K 175.42% | 2.36M 481.79% | 1.97M 16.47% | 766.63K 61.10% | 1.34M 74.49% | |||||
other working capital | -514 - | -604.29K 117,465.76% | 2.24M 470.18% | 1.10M 50.74% | -450K 140.84% | -300K 33.33% | -1.70M 467.84% | 95.46K 105.60% | 90.07K 5.64% | -66.96K 174.34% | |
other non cash items | 198.14K - | 148.07K 25.27% | 56.16K 62.07% | 110.87K 97.43% | 387.21K 249.24% | 248.93K 35.71% | 40.39K 83.77% | 764.78K 1,793.50% | 1.08M 41.36% | 83.72K 92.26% | |
net cash provided by operating activities | -6.93M - | -1.71M 75.24% | -3.78M 120.55% | -6.25M 65.38% | -6.11M 2.39% | -12.51M 104.87% | -6.66M 46.73% | 112.11K 101.68% | -2.46M 2,295.50% | -1.39M 43.60% | |
investments in property plant and equipment | -122.02K - | -768.97K 530.22% | -430.48K 44.02% | -515.41K 19.73% | -1.82M 253.84% | -101.18K 94.45% | -14.47K 85.69% | -3.88K 73.23% | |||
acquisitions net | |||||||||||
purchases of investments | |||||||||||
sales maturities of investments | |||||||||||
other investing activites | 29.19K - | 500K - | |||||||||
net cash used for investing activites | -122.02K - | -768.97K 530.22% | -430.48K 44.02% | -515.41K 19.73% | -1.82M 253.84% | -101.18K 94.45% | -14.47K 85.69% | 25.32K 274.91% | 500K - | ||
debt repayment | -49.99K - | -792.76K 1,485.88% | -27.49K 96.53% | -21.29K 22.55% | -164.83K 674.17% | -461.92K - | |||||
common stock issued | 6.20M - | 6.57M 6.05% | 1.29M 80.37% | 10.11M 683.62% | 6.54M 35.30% | 19.64M 200.31% | 3.07M - | ||||
common stock repurchased | |||||||||||
dividends paid | |||||||||||
other financing activites | 1.18M - | 178.37K 84.90% | 471.19K 164.17% | -929.15K 297.19% | -694.64K 25.24% | -2.29M 229.66% | 562.82K 124.58% | -38.22K - | 200K 623.29% | ||
net cash used provided by financing activities | 7.33M - | 5.96M 18.71% | 1.73M 70.89% | 9.16M 428.28% | 5.68M 37.97% | 17.35M 205.43% | 100.90K 99.42% | 3.03M - | 200K 93.40% | ||
effect of forex changes on cash | -16.04K - | ||||||||||
net change in cash | 263.57K - | 3.47M 1,217.82% | -2.48M 171.36% | 2.39M 196.39% | -2.25M 194.06% | 4.74M 311.13% | -6.58M 238.62% | 137.42K 102.09% | 569.90K 314.70% | -688.22K 220.76% | |
cash at beginning of period | 497.02K - | 760.59K 53.03% | 4.23M 456.67% | 1.76M 58.54% | 4.14M 136.12% | 1.90M 54.23% | 6.64M 250.11% | 64.62K 99.03% | 202.05K 212.66% | 771.95K 282.06% | |
cash at end of period | 760.59K - | 4.23M 456.67% | 1.76M 58.54% | 4.14M 136.12% | 1.90M 54.23% | 6.64M 250.11% | 64.62K 99.03% | 202.05K 212.66% | 771.95K 282.06% | 83.72K 89.15% | |
operating cash flow | -6.93M - | -1.71M 75.24% | -3.78M 120.55% | -6.25M 65.38% | -6.11M 2.39% | -12.51M 104.87% | -6.66M 46.73% | 112.11K 101.68% | -2.46M 2,295.50% | -1.39M 43.60% | |
capital expenditure | -122.02K - | -768.97K 530.22% | -430.48K 44.02% | -515.41K 19.73% | -1.82M 253.84% | -101.18K 94.45% | -14.47K 85.69% | -3.88K 73.23% | |||
free cash flow | -7.05M - | -2.48M 64.76% | -4.21M 69.60% | -6.77M 60.72% | -7.93M 17.12% | -12.61M 59.03% | -6.68M 47.04% | 108.23K 101.62% | -2.46M 2,374.10% | -1.39M 43.60% |
All numbers in (except ratios and percentages)